PRPO News and Press, Precipio Inc. From 11/03/21

SAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Kathy...

NEW HAVEN, Conn., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q3-2021 update call on Monday, November 15 th at 5:00 PM ET. The call will include updates on the company’s current core businesses...

While Precipio (PRPO) is a lesser-known company in the diagnostics and research industry, it generated significant market buzz in May 2021 when its COVID-19 antibody test became available on Amazon’s (AMZN) platform. However, can the stock continue to advance by relying on the antibody...

Gainers: NeuroMetrix (NASDAQ:NURO) +54%, Reneo Pharmaceuticals (NASDAQ:RPHM) +24%, Neoleukin Therapeutics (NASDAQ:NLTX) +21%, Chembio Diagnostics (NASDAQ:CEMI) +17%, InspireMD (NASDAQ:NSPR) +14%. Losers: Cassava Sciences (NASDAQ:SAVA) -28%, Applied Ther...

Start Time: 17:00 End Time: 17:12 Precipio, Inc. (PRPO) Q2 2021 Earnings Conference Call August 26, 2021, 17:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Presentation Operator Welcome to the Precipio’s Shareholder Second Quarter 2021 Shareholder Update ...

NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , and American Oncology Network , LLC (AON), a high-growth community oncology provider, announces the signing of an agreeme...

BILL, DELL, DOMO, GPS, HPQ, LTRX, MRVL, OLLI, OTCQX:PLNHF, PRPO, PTON, RCEL, VMW, WDAY For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close

NEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be rescheduling its Q2-2021 update call from Monday August 23 rd to Thursday, August 26 th at 5:00 PM ET due to a schedule conflict. The confer...

NEW HAVEN, Conn., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2021 update call on Monday, August 23 rd at 5:00 PM ET. The call will include discussions on all of the company’s core businesse...

NEW HAVEN, Conn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2021 update call on Monday, August 23 rd at 5:00 PM ET. The call will include updates on all of the company’s current core busin...